Expression profiling of uterine leiomyomata cytogenetic subgroups reveals distinct signatures in matched myometrium: transcriptional profilingof the t(12;14) and evidence in support of predisposing genetic heterogeneity.

Uterine leiomyomata (UL), the most common neoplasm in reproductive-age women, are classified into distinct genetic subgroups based on recurrent chromosome abnormalities. To develop a molecular signature of UL with t(12;14)(q14-q15;q23-q24), we took advantage of the multiple UL arising as independent clonal lesions within a single uterus. We compared genome-wide expression levels of t(12;14) UL to non-t(12;14) UL from each of nine women in a paired analysis, with each sample weighted for the percentage of t(12;14) cells to adjust for mosaicism with normal cells. This resulted in a transcriptional profile that confirmed HMGA2, known to be overexpressed in t(12;14) UL, as the most significantly altered gene. Pathway analysis of the differentially expressed genes showed significant association with cell proliferation, particularly G1/S checkpoint regulation. This is consistent with the known larger size of t(12;14) UL relative to karyotypically normal UL or to UL in the deletion 7q22 subgroup. Unsupervised hierarchical clustering demonstrated that patient variability is relatively dominant to the distinction of t(12;14) UL compared with non-t(12;14) UL or of t(12;14) UL compared with del(7q) UL. The paired design we employed is therefore important to produce an accurate t(12;14) UL-specific gene list by removing the confounding effects of genotype and environment. Interestingly, myometrium not only clustered away from the tumors, but generally separated based on associated t(12;14) versus del(7q) status. Nine genes were identified whose expression can distinguish the myometrium origin. This suggests an underlying constitutional genetic predisposition to these somatic changes which could potentially lead to improved personalized management and treatment.

[1]  D. Ann,et al.  Oncogenic Raf-1 Induces the Expression of Non-histone Chromosomal Architectural Protein HMGI-C via a p44/p42 Mitogen-activated Protein Kinase-dependent Pathway in Salivary Epithelial Cells* , 1997, The Journal of Biological Chemistry.

[2]  D. Haussler,et al.  Integration of cytogenetic landmarks into the draft sequence of the human genome , 2001, Nature.

[3]  Gordon K Smyth,et al.  Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2004, Statistical applications in genetics and molecular biology.

[4]  P. Hinds,et al.  cdk6 Can Shorten G1 Phase Dependent upon the N-terminal INK4 Interaction Domain* , 1999, The Journal of Biological Chemistry.

[5]  J. B. Williams,et al.  Growth factor-induced delayed early response genes , 1992, Molecular and cellular biology.

[6]  Richa Saxena,et al.  A common variant of HMGA2 is associated with adult and childhood height in the general population , 2007, Nature Genetics.

[7]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. Sklar,et al.  Analysis of androgen receptor DNA reveals the independent clonal origins of uterine leiomyomata and the secondary nature of cytogenetic aberrations in the development of leiomyomata , 1994, Genes, chromosomes & cancer.

[9]  B. Katzenellenbogen,et al.  Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[10]  H. Hameister,et al.  The expression pattern of the Hmgic gene during development , 1998, Genes, chromosomes & cancer.

[11]  E. Wallach,et al.  Uterine leiomyomata: etiology, symptomatology, and management. , 1981, Fertility and sterility.

[12]  C. Panhuysen,et al.  Uterine leiomyomata and decreased height: a common HMGA2 predisposition allele , 2009, Human Genetics.

[13]  B. Moor,et al.  Microarray screening for target genes of the proto-oncogene PLAG1 , 2004, Oncogene.

[14]  C. Azuma,et al.  Clonal determination of uterine leiomyomas by analyzing differential inactivation of the X-chromosome-linked phosphoglycerokinase gene. , 1995, Gynecologic and obstetric investigation.

[15]  R Grosschedl,et al.  HMG domain proteins: architectural elements in the assembly of nucleoprotein structures. , 1994, Trends in genetics : TIG.

[16]  M. Nissen,et al.  Phosphorylation by cdc2 kinase modulates DNA binding activity of high mobility group I nonhistone chromatin protein. , 1991, Journal of Biological Chemistry.

[17]  K. Münger,et al.  Elevated activity of cyclin-dependent kinase 6 in human squamous cell carcinoma lines. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[18]  S. Weremowicz,et al.  HMGA2 expression in uterine leiomyomata and myometrium: Quantitative analysis and tissue culture studies , 2003, Genes, chromosomes & cancer.

[19]  Alberto Riva,et al.  Defining aggressive prostate cancer using a 12-gene model. , 2006, Neoplasia.

[20]  J. Easton,et al.  Disruption of the cyclin D/cyclin-dependent kinase/INK4/retinoblastoma protein regulatory pathway in human neuroblastoma. , 1998, Cancer research.

[21]  A. Skubitz,et al.  Differential gene expression in uterine leiomyoma. , 2003, The Journal of laboratory and clinical medicine.

[22]  K. Lohr,et al.  Management of uterine fibroids: an update of the evidence. , 2007, Evidence report/technology assessment.

[23]  A. Wolffe.  Architectural transcription factors. , 1994, Science.

[24]  B. Wold,et al.  Cloning of mid-G1 serum response genes and identification of a subset regulated by conditional myc expression. , 1994, Molecular biology of the cell.

[25]  M. Farrell,et al.  Annual Costs Associated With Diagnosis of Uterine Leiomyomata , 2006, Obstetrics and gynecology.

[26]  D G Oscier,et al.  The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. , 2001, Blood.

[27]  R. Cantor,et al.  Cytogenetic abnormalities in uterine myomas are associated with myoma size. , 1998, Molecular human reproduction.

[28]  B. Morrow,et al.  Hysterectomy surveillance--United States, 1980-1993. , 1997, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[29]  W. V. D. Van de Ven,et al.  The tumorigenic diversity of the three PLAG family members is associated with different DNA binding capacities. , 2002, Cancer research.

[30]  K. Chada,et al.  Genomic structure and expression of the murine Hmgi-c gene. , 1996, Nucleic acids research.

[31]  O. Myklebost,et al.  HMGIC, the gene for an architectural transcription factor, is amplified and rearranged in a subset of human sarcomas , 1997, Oncogene.

[32]  Yusuke Nakamura,et al.  A genome-wide association study identifies three loci associated with susceptibility to uterine fibroids , 2011, Nature Genetics.

[33]  J. Bullerdiek,et al.  Chromosomal translocations affecting 12q14-15 but not deletions of the long arm of chromosome 7 associated with a growth advantage of uterine smooth muscle cells. , 1999, Molecular human reproduction.

[34]  M. Azim Surani,et al.  Abnormal maternal behaviour and growth retardation associated with loss of the imprinted gene Mest , 1998, Nature Genetics.

[35]  S. Heim,et al.  Uterine leiomyoma cytogenetics , 1990, Genes, chromosomes & cancer.

[36]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[37]  F. Nielsen,et al.  A Family of Insulin-Like Growth Factor II mRNA-Binding Proteins Represses Translation in Late Development , 1999, Molecular and Cellular Biology.

[38]  A. Patel,et al.  The frequency of uterine leiomyomas. , 1990, American journal of clinical pathology.

[39]  R. Sciot,et al.  HMGA 2 Regulates Transcription of the Imp 2 Gene via an Intronic Regulatory Element in Cooperation with Nuclear Factor-K B , 2007 .

[40]  Cheng Li,et al.  Adjusting batch effects in microarray expression data using empirical Bayes methods. , 2007, Biostatistics.

[41]  P. Rogalla,et al.  HMGI-C expression patterns in human tissues. Implications for the genesis of frequent mesenchymal tumors. , 1996, The American journal of pathology.

[42]  J. Fletcher,et al.  Cytogenetic Abnormalities in Uterine Leiomyomata , 1991, Obstetrics and gynecology.

[43]  C. Morton,et al.  HMGIC expression in human adult and fetal tissues and in uterine leiomyomata , 1999, Genes, chromosomes & cancer.

[44]  Xianjin Zhou,et al.  Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C , 1995, Nature.

[45]  P. Park,et al.  Identifying the molecular signature of the interstitial deletion 7q subgroup of uterine leiomyomata using a paired analysis , 2009, Genes, chromosomes & cancer.

[46]  A. Fusco,et al.  Roles of HMGA proteins in cancer , 2007, Nature Reviews Cancer.

[47]  G. Semenza.  Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.

[48]  P. Cin,et al.  Clinical significance of cytogenetic abnormalities in uterine myomas. , 1998, Fertility and sterility.

[49]  P. Cin,et al.  Uterine Leiomyomata with t(10;17) Disrupt the Histone Acetyltransferase MORF , 2004, Cancer Research.

[50]  M. Gossen,et al.  Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. , 1994, Molecular and cellular biology.

[51]  R. Sciot,et al.  HMGA2 Regulates Transcription of the Imp2 Gene via an Intronic Regulatory Element in Cooperation with Nuclear Factor-κB , 2007, Molecular Cancer Research.

[52]  S. Schwartz,et al.  Complications in Pregnancy, Labor, and Delivery with Uterine Leiomyomas: A Population‐Based Study , 2000, Obstetrics and gynecology.

[53]  S. Gartler,et al.  Glucose-6-Phosphate Dehydrogenase Mosaicism: Utilization as a Cell Marker in the Study of Leiomyomas , 1965, Science.

[54]  Ruud Delwel,et al.  Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11. , 2005, Blood.

[55]  Terrence S. Furey,et al.  The UCSC Genome Browser Database , 2003, Nucleic Acids Res..

[56]  W Arap,et al.  Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA. , 1997, Cancer research.

[57]  Cynthia C Morton,et al.  Constitutional rearrangement of the architectural factor HMGA2: a novel human phenotype including overgrowth and lipomas. , 2005, American journal of human genetics.

[58]  M. Ohmichi,et al.  Prolactin stimulates mitogen-activated protein kinase in human leiomyoma cells. , 1997, Biochemical and biophysical research communications.

[59]  R. Chetty,et al.  Cyclin D1 and human neoplasia. , 1998, Molecular pathology : MP.

[60]  S. Datta,et al.  Health care resource use for uterine fibroid tumors in the United States. , 2006, American journal of obstetrics and gynecology.

[61]  L. Castilla,et al.  Plag 1 and Plagl 2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH 11 , 2004 .

[62]  M. Tang,et al.  Gene expression studies provide clues to the pathogenesis of uterine leiomyoma: new evidence and a systematic review. , 2005, Human reproduction.

[63]  E. Schoenmakers,et al.  Identification of NFIB as recurrent translocation partner gene of HMGIC in pleomorphic adenomas , 1998, Oncogene.

[64]  W. V. D. Van de Ven,et al.  Targeted disruption of the murine Plag1 proto‐oncogene causes growth retardation and reduced fertility , 2004, Development, growth & differentiation.

[65]  K. Chada,et al.  Genomic characterization of human HMGIC, a member of the accessory transcription factor family found at translocation breakpoints in lipomas. , 1996, Genomics.

[66]  S. Rho,et al.  Calpain 6 supports tumorigenesis by inhibiting apoptosis and facilitating angiogenesis. , 2008, Cancer letters.

[67]  E. Stewart,et al.  Prolactin Is an Autocrine or Paracrine Growth Factor for Human Myometrial and Leiomyoma Cells , 1999, Gynecologic and Obstetric Investigation.

[68]  R. Reeves,et al.  Molecular biology of HMGA proteins: hubs of nuclear function. , 2001, Gene.

[69]  Richard O C Oreffo,et al.  Hypoxia inducible factors regulate pluripotency and proliferation in human embryonic stem cells cultured at reduced oxygen tensions , 2010, Reproduction.

[70]  E. Stewart,et al.  New concepts in the treatment of uterine leiomyomas. , 1998, Obstetrics and gynecology.

[71]  U. Surti,et al.  Uterine Leiomyomas: Cytogenetic and Histologic Profile , 1992, Obstetrics and gynecology.

[72]  D. Steinemann,et al.  The BCL 11 gene family : involvement of BCL 11 A in lymphoid malignancies , 2001 .

[73]  Herman Van den Berghe,et al.  Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours , 1995, Nature Genetics.

[74]  K. Marchal,et al.  Differential regulation of the insulin‐like growth factor II mRNA‐binding protein genes by architectural transcription factor HMGA2 , 2004, FEBS letters.

[75]  T. Ayoubi,et al.  Regulation of HMGIC expression: an architectural transcription factor involved in growth control and development , 1999, Oncogene.

[76]  John D. Storey,et al.  Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[77]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.